Who is sponsoring NCT05591014?

NCT05591014 is sponsored by University of Utah.

What drugs are being tested in NCT05591014?

Interventions in NCT05591014: Novel ROTEM interpretation software.

What condition does NCT05591014 study?

NCT05591014 studies Coagulation Disorder, Blood.

Is NCT05591014 still recruiting?

NCT05591014 is currently completed. Last updated 2 April 2025.

Last reviewed 2025-04-02 · How we verify

NCT05591014

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effectiveness of a Novel Software Program to Help in ROTEM Interpretation

Completed NA Last updated 2 April 2025

What this trial tests

NA trial testing Novel ROTEM interpretation software in Coagulation Disorder, Blood in 60 participants. Completed in 31 December 2024.

Timeline

13 April 2023

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	University of Utah
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	60
Start date	13 April 2023
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across United States

Drugs / interventions tested

Novel ROTEM interpretation software

Conditions studied

Coagulation Disorder, Blood — all drugs for Coagulation Disorder, Blood →

Sponsor

University of Utah

Who can join

18 and older, any sex, with Coagulation Disorder, Blood. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess a novel rotational thromboelastometry (ROTEM®) interpretation software to determine whether its use improves the accuracy of clinician interpretation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Coagulation Disorder, Blood

Currently open trials in the same condition.

NCT05806346 — Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery · NA · recruiting

Other University of Utah trials

Trials by the same sponsor.

NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies · NA · not yet recruiting
NCT07225426 — Personalizing Financial Incentives · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers · NA · not yet recruiting
NCT04208984 — Diversion Device With Breath Control · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05591014 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 2 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05591014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing